
ASH · NYSE
Ashland Inc.
$73.02 +0.71 (+0.99%)
Company overview
Ashland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care and Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions.
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Exchange
- NYSE
- Market cap
- $3.3B
- Employees
- 3,200
- Headquarters
- Wilmington, DE
- Website
- ashland.com
- CEO
- Guillermo Novo
- Listed
- March 17, 1980
- P/E
- -4.76
- Dividend yield
- 2.21%
Company financials
- Revenue
- $1.8B
- Gross profit
- $456M
- Operating income
- $78M
- EBITDA
- $368M
- Net income
- -$706M
- EPS
- -$15.34
- Total assets
- $4.5B
- Total debt
- $1.5B
- Gross margin
- 25.21%
- Net margin
- -39.03%
- Earnings yield
- -21.01%
No annual geographic segmentation.
Showing FY 2025